872P Safety and efficacy of toripalimab combined with cetuximab in PD-L1 positive untreated recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase Ib/II study
Year: 2024
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: Tongji University, Shanghai East Hospital, Liaoning Cancer Hospital & Institute, Hunan Cancer Hospital, Kunming Medical University, Jiangsu Cancer Hospital, Third Affiliated Hospital of Harbin Medical University, Zhejiang Provincial People's Hospital, Hubei Cancer Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Central South University, Xiangya Hospital Central South University, Fujian Provincial Cancer Hospital, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University, Sun Yat-sen University Cancer Center, Peking University Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, West China Hospital of Sichuan University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402561275